Gene: CAAP1
Official Full Name: caspase activity and apoptosis inhibitor 1provided by HGNC
Gene Summary: Involved in negative regulation of cysteine-type endopeptidase activity. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19130 | CAAP1 Knockout cell line (HeLa) | Human | CAAP1 | 1:3~1:6 | Negative | Online Inquiry |
KO19131 | CAAP1 Knockout cell line (HCT 116) | Human | CAAP1 | 1:2~1:4 | Negative | Online Inquiry |
KO19132 | CAAP1 Knockout cell line (HEK293) | Human | CAAP1 | 1:3~1:6 | Negative | Online Inquiry |
KO19133 | CAAP1 Knockout cell line (A549) | Human | CAAP1 | 1:3~1:4 | Negative | Online Inquiry |
CAAP1 Gene Knockout Cell Lines are specifically engineered cellular models that have undergone targeted gene disruption of the CAAP1 gene, a crucial component implicated in a variety of cellular processes including cell signaling, apoptosis, and differentiation. By employing CRISPR-Cas9 technology, these cell lines enable researchers to study the functional impacts of CAAP1 absence, providing valuable insights into its role in health and disease.
The key functionality of the CAAP1 Gene Knockout Cell Lines lies in their ability to facilitate precise gene editing, allowing for controlled experimental conditions that explore CAAP1's contribution to pathological states such as cancer, neurodegenerative disorders, and metabolic syndromes. Through these knockout models, researchers can assess changes in cellular behavior, gene expression profiles, and signaling pathways, leading to a better understanding of disease mechanisms.
Scientifically, CAAP1 Gene Knockout Cell Lines are vital in translational research and therapeutic development. Their applications span various domains, including drug discovery, where they can be utilized to screen for compounds that specifically target pathways affected by CAAP1 loss. Furthermore, they serve as a platform for validating potential biomarkers and therapeutic targets.
When compared to alternative models like conventional knockdown cells or wild-type controls, the CAAP1 Gene Knockout Cell Lines offer superior reliability and specificity, as they provide a complete absence of the target gene rather than a mere reduction in expression. This provides greater clarity in experimental outcomes and enhances reproducibility.
The use of CAAP1 Gene Knockout Cell Lines offers unparalleled value to researchers and clinicians who seek to unravel complex biological questions and develop novel therapeutic strategies. By equipping scientists with advanced tools tailored for accuracy and efficacy, these cell lines contribute significantly to the progression of biomedical research.
Our company prides itself on its commitment to providing high-quality research tools, underpinned by extensive expertise and a dedication to advancing scientific discovery. With a comprehensive product offering that includes a variety of gene knockout models, we support the research community in their quest for innovative solutions in health and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.